Catherine A. Sohn Insider Trading
Get free email notifications about insider trading for Catherine A. Sohn.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Catherine A. Sohn. Catherine A. Sohn is a in LANDEC CORP \CA\ ($LNDC) and a Director in LANDEC CORP \CA\ ($LNDC) and a Director in Jazz Pharmaceuticals plc ($JAZZ) and a Director in Neuralstem, Inc. ($CUR) and a Director in Axcella Health Inc. ($AXLA) and a Director in Rubius Therapeutics, Inc. ($RUBY).
Address: C/O JAZZ PHARMACEUTICALS PLC 45 FITZWILLIAM SQUARE DUBLIN 2 Ireland
Companies in which Catherine A. Sohn is an Insider
Axcella Health Inc.
Trading Symbol: AXLAIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Catherine A. Sohn: Director
Holdings: 1,000 shares
Latest Transaction: May 22 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Jazz Pharmaceuticals plc
Trading Symbol: JAZZIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Catherine A. Sohn: Director
Holdings: 15,122 shares
Current Value: $1,891,006
Latest Transaction: Nov 06 2020
$JAZZ Market Capitalization: $7.62B
$JAZZ Previous Close: $125.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
LANDEC CORP \CA\
Trading Symbol: LNDCIndustry: CANNED, FRUITS, VEG & PRESERVES, JAMS & JELLIES [2033]
Position of Catherine A. Sohn:
Holdings: 47,010 shares
Current Value: $589,976
Latest Transaction: Jun 03 2021
$LNDC Market Capitalization: $346.33M
$LNDC Previous Close: $12.55
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PALISADE BIO, INC.
Trading Symbol: SNCAIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Catherine A. Sohn: Director
Holdings: 106,952 shares
Current Value: $322,995
Latest Transaction: Jul 06 2015
$SNCA Market Capitalization: $28.01M
$SNCA Previous Close: $3.02
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Rubius Therapeutics, Inc.
Trading Symbol: RUBYIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Catherine A. Sohn: Director
Holdings: 2,500 shares
Latest Transaction: May 13 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Catherine A. Sohn
Sentiment: All, AXLA, JAZZ, LNDC, SNCA, RUBY
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 03 2021 | LNDC | LANDEC CORP \CA\ | Sohn Catherine A. | Option Exercise | M | 0.00 | 8,303 | 0 | 0 | ||
Jun 03 2021 | LNDC | LANDEC CORP \CA\ | Sohn Catherine A. | Grant | A | 11.64 | 8,303 | 96,647 | 47,010 | 38.7 K to 47 K (+21.45 %) | |
Jun 03 2021 | LNDC | LANDEC CORP \CA\ | Sohn Catherine A. | Option Exercise | M | 0.00 | 8,303 | 0 | 0 | ||
Jun 03 2021 | LNDC | LANDEC CORP \CA\ | Sohn Catherine A. | Grant | A | 11.64 | 8,303 | 96,647 | 47,010 | 38.7 K to 47 K (+21.45 %) | |
May 13 2021 | RUBY | Rubius Therapeutic ... | Sohn Catherine A. | Director | Option Exercise | A | 23.25 | 25,000 | 581,250 | 25,000 | |
Nov 06 2020 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Option Exercise | M | 81.76 | 4,500 | 367,920 | 0 | |
Nov 06 2020 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Option Exercise | M | 46.83 | 8,000 | 374,640 | 0 |